Merck tests antibiotics waters again as FDA OKs Zerbaxa's expanded use in pneumonia
In a rare Big Pharma advance in the antibiotics field, Merck has revived hopes for Zerbaxa with a new approval for two …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
